Centocor, Inc. Clinical Trial
Centocor, Inc.
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Centocor, Inc. Clinical Trial as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:19 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT01362153 · A Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of Golimumab in Patients With Rheumatoid Arthritis (RA)Centocor, Inc. · completed · Rheumatoid Arthritis · study director
- Ph1NCT01288157 · A Study of the Pharmacokinetics of Golimumab in Chinese Male SubjectsCentocor, Inc. · completed · Healthy Adult Chinese Males · study director
- Ph3NCT01266811 · A Phase 3 Study of Siltuximab or Placebo in Combination With Velcade and Dexamethasone in Patients With Relapsed or Refractory Multiple MyelomaCentocor, Inc. · withdrawn · Multiple Myeloma · study director
- Ph1NCT01258777 · A Study of the Pharmacokinetics of Golimumab in Japanese and Caucasian Male SubjectsCentocor, Inc. · completed · Healthy Volunteers · study director
- Ph3NCT01248780 · Study of Subcutaneous Golimumab in Chinese Patients With Active Rheumatoid Arthritis Despite Methotrexate TherapyCentocor, Inc. · completed · Rheumatoid Arthritis · study director
- Ph3NCT01248793 · Study of the Safety and Efficacy of Golimumab in Chinese Patients With Ankylosing SpondylitisCentocor, Inc. · completed · Ankylosing Spondylitis · study director
- Ph1NCT01204996 · A Study of the Safety and Efficacy of CNTO 888 in Combination With SoC (Standard of Care) Chemotherapy in Patients With Solid TumorsCentocor, Inc. · completed · Cancer · study director
- Ph1NCT01195207 · A Phase 1 Study of CNTO 3157 in Healthy Volunteers and Patients With AsthmaCentocor, Inc. · completed · Asthma · study director
- Ph1NCT01081704 · A Study of the Pharmacokinetics of Ustekinumab in Chinese Male SubjectsCentocor, Inc. · completed · Healthy · study director
- Ph1NCT01081691 · A Study Evaluating Intravenous and Subcutaneous Administration of a Human Monoclonal Antibody (CNTO 5825) in Healthy VolunteersCentocor, Inc. · completed · Healthy · study director
- Ph3NCT01008995 · A Study of the Safety and Effectiveness of Ustekinumab (Stelara) in Chinese Patients With PsoriasisCentocor, Inc. · completed · Psoriasis · study director
- Ph3NCT00973479 · An Effectiveness and Safety Study of Intravenous Golimumab in Patients With Active Rheumatoid Arthritis Despite Treatment With Methotrexate TherapyCentocor, Inc. · completed · Arthritis, Rheumatoid · study director
- Ph2NCT00955279 · A Study to Evaluate the Safety and Effectiveness of Ustekinumab or Golimumab Administered Subcutaneously (SC) in Patients With SarcoidosisCentocor, Inc. · completed · Sarcoidosis · study director
- Ph1NCT00925574 · A Study of the Safety and How the Body Affects a Drug (CNTO 1959) in Healthy Volunteers and in Patients With PsoriasisCentocor, Inc. · completed · Psoriasis · study director
- Ph1NCT00844909 · A Study of the Safety and How the Body Effects a Drug CNTO 136 in Healthy Male Japanese and Caucasian VolunteersCentocor, Inc. · completed · Healthy · study director
- Ph1/Ph2NCT00841191 · A Safety, Efficacy and Pharmacokinetic Study of Siltuximab (CNTO 328) in Participants With Solid TumorsCentocor, Inc. · completed · Ovarian Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms · study director
- Ph2NCT00786201 · A Study to Evaluate the Safety and Effectiveness of CNTO 888 Administered Intravenously (IV) in Participants With Idiopathic Pulmonary Fibrosis (IPF)Centocor, Inc. · completed · Pulmonary Fibrosis · study director
- Ph2NCT00771667 · A Study of Safety and Effectiveness of Ustekinumab in Patients With Moderate to Severe Active Crohn's Disease Who Have Been Previously Treated With Anti-TNF TherapyCentocor, Inc. · completed · Crohn's Disease · study director
- Ph3NCT00747344 · A Phase 3 Trial to Look at the Safety and Effectiveness of Ustekinumab in Korean and Taiwanese Subjects With Moderate to Severe Plaque-type PsoriasisCentocor, Inc. · completed · Psoriasis · study director
- Ph2NCT00675649 · A Clinical Trial Evaluating the Safety and Effectiveness of Golimumab in Patients With Severe, Persistent AsthmaCentocor, Inc. · withdrawn · Asthma · study director
- Early Ph1NCT00643526 · A Study to Test the Design, Functionality, and Ergonomic Features of the AutoinjectorCentocor, Inc. · completed · Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis · study director
- Ph1NCT00537368 · First Study of the Safety of CNTO 888 in Patients With Solid TumorsCentocor, Inc. · completed · Cancer · study director
- Ph2NCT00537381 · An Efficacy and Safety Study of Intetumumab (CNTO 95) in Participants With Metastatic Hormone Refractory Prostate CancerCentocor, Inc. · completed · Prostatic Neoplasms · study director
- Ph1NCT00458575 · A Study to Evaluate the Safety of CNTO 2476 in Patients With Advanced Retinitis PigmentosaCentocor, Inc. · terminated · Retinitis Pigmentosa · study director
- Ph3NCT00454584 · An Efficacy and Safety Study of CNTO 1275 Compared to Etanercept in Patients With Plaque PsoriasisCentocor, Inc. · completed · Psoriasis · study director
- Ph1NCT00412321 · A Safety and Efficacy Study of CNTO 328 in Patients With B-Cell Non-Hodgkin's Lymphoma, Multiple Myeloma, or Castleman's DiseaseCentocor, Inc. · completed · Lymphoma, Non-Hodgkin, Multiple Myeloma, Giant Lymph Node Hyperplasia · study director
- Ph1NCT00401765 · A Study of CNTO 328 in Patients With Metastatic Hormone-Refractory Prostate CancerCentocor, Inc. · completed · Prostatic Neoplasms · study director
- Ph2NCT00402181 · An Efficacy and Safety Study of Siltuximab in Participants With Relapsed or Refractory Multiple MyelomaCentocor, Inc. · completed · Multiple Myeloma · study director
- Ph2NCT00385827 · A Safety and Efficacy Study of Siltuximab (CNTO 328) in Male Subjects With Metastatic Hormone-Refractory Prostate Cancer (HRPC)Centocor, Inc. · terminated · Cancer, Prostate · study director
- N/ANCT00380796 · A Long-term Safety Study of Infliximab in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD).Centocor, Inc. · completed · COPD, Pulmonary Disease, Chronic Obstructive · study director
- Ph4NCT00378261 · APART Advanced Profiling of Anti-Rheumatic TherapiesCentocor Ortho Biotech Services, L.L.C. · completed · Arthritis, Rheumatoid · study director
- Ph3NCT00361335 · A Study of Safety and Effectiveness of Golimumab in Participants With Active Rheumatoid Arthritis Despite Methotrexate TherapyCentocor, Inc. · completed · Rheumatoid Arthritis · study director
- Ph3NCT00336492 · A Study of the Safety and Efficacy of Infliximab(REMICADE ) in Pediatric Patients With Moderately to SeverelyActive Ulcerative ColitisCentocor, Inc. · completed · Ulcerative Colitis · study director
- Ph2NCT00320216 · A Safety and Effectiveness Study of CNTO 1275 in Patients With Moderate to Severe Plaque-type PsoriasisCentocor, Inc. · completed · Psoriasis · study director
- Ph3NCT00307437 · A Study of the Safety and Efficacy of Ustekinumab (CNTO 1275) in Patients With Moderate to Severe PsoriasisCentocor Research & Development, Inc. · completed · Psoriasis · study director
- Ph3NCT00299546 · A Study of the Safety and Efficacy of Golimumab (CNTO 148) in Subjects With Active Rheumatoid Arthritis Previously Treated With Biologic Anti-TNFa Agent(s)Centocor, Inc. · completed · Arthritis, Rheumatoid · study director
- Ph3NCT00271401 · A Study Comparing the Efficacy and Safety of Intracoronary Stenting With or Without Abciximab, an Anti-Platelet Therapy, and Conventional Coronary Angioplasty With AbciximabCentocor, Inc. · completed · Angioplasty, Transluminal, Percutaneous Coronary · study director
- Ph3NCT00269906 · A Study Evaluating the Efficacy and Safety of Abciximab, an Anti-Platelet Therapy, in Patients With Unstable Angina Not Responding to Standard Medical Therapy Who Are Eligible for Coronary AngioplastyCentocor, Inc. · completed · Angina, Unstable, Angioplasty, Transluminal, Percutaneous Coronary · study director
- Ph3NCT00269867 · Infliximab Plus Methotrexate for the Treatment of Rheumatoid ArthritisCentocor, Inc. · completed · Rheumatoid Arthritis · study director
- Ph3NCT00269880 · A Study Comparing the Efficacy and Safety of Abciximab, an Anti-Platelet Therapy, in Combination With Two Different Heparin Regimens in Patients Undergoing Percutaneous Coronary Intervention.Centocor, Inc. · completed · Angioplasty, Transluminal, Percutaneous Coronary · study director
- Ph3NCT00269841 · An Efficacy and Safety Study of Anti-TNF Monoclonal Antibody in Patients With Fistulizing Crohn's DiseaseCentocor, Inc. · completed · Crohn Disease · study director
- Ph3NCT00269893 · A Study Evaluating the Efficacy and Safety of Abciximab, an Anti-platelet Therapy, in Patients Undergoing High-risk Coronary AngioplastyCentocor, Inc. · completed · Angina, Unstable, Angioplasty, Transluminal, Percutaneous Coronary · study director
- Ph2/Ph3NCT00269854 · An Efficacy and Safety Study of Anti-TNF Monoclonal Antibody in Patients With Crohn's DiseaseCentocor, Inc. · completed · Crohn Disease · study director
- Ph2NCT00267956 · An Effectiveness and Safety Study of CNTO 1275 in Patients With Active Psoriatic ArthritisCentocor, Inc. · completed · Psoriatic Arthritis · study director
- Ph3NCT00265083 · A Study of the Safety and Efficacy of Golimumab in Subjects With Active Ankylosing SpondylitisCentocor, Inc. · completed · Spondylitis, Ankylosing · study director
- Ph3NCT00265096 · A Study of the Safety and Efficacy of Golimumab in Patients With Active Psoriatic ArthritisCentocor, Inc. · completed · Arthritis, Psoriatic · study director
- Ph1/Ph2NCT00265135 · A Study of CNTO 328 in Subjects With Metastatic Renal Cell CarcinomaCentocor, Inc. · completed · Carcinoma, Renal Cell · study director
- Ph3NCT00264550 · An Efficacy and Safety Study of Golimumab in Patients With Active Rheumatoid Arthritis Despite Methotrexate TherapyCentocor, Inc. · completed · Rheumatoid Arthritis · study director
- Ph3NCT00264537 · A Study of the Safety and Efficacy of Golimumab in Subjects With Rheumatoid Arthritis That Are Methotrexate-naiveCentocor, Inc. · completed · Rheumatoid Arthritis · study director
- N/ANCT00261976 · A Long-term Safety Study of Infliximab (Remicade)Centocor, Inc. · completed · Arthritis, Rheumatoid, Crohn Disease, Psoriasis · study director
- Ph1/Ph2NCT00246012 · A Safety and Efficacy Study of Intetumumab, Alone and in Combination With Dacarbazine, in Participants With Stage 4 MelanomaCentocor, Inc. · completed · Melanoma · study director
- Ph3NCT00236028 · A Safety and Efficacy Study for Infliximab (Remicade) With Methotrexate in Patients With Early Rheumatoid ArthritisCentocor, Inc. · completed · Rheumatoid Arthritis · study director
- Ph2NCT00230529 · A Safety and Efficacy Study of Infliximab (Remicade) in Patients With Plaque Type PsoriasisCentocor, Inc. · completed · Psoriasis · study director
- Ph2NCT00207740 · A Study of Safety and Efficacy of CNTO 148 in Patients With Severe Persistent AsthmaCentocor, Inc. · completed · Asthma · study director
- Ph3NCT00207701 · A Study of Infliximab (Remicade) in Patients With Ankylosing Spondylitis.Centocor, Inc. · completed · Ankylosing Spondylitis · study director
- Ph3NCT00207675 · A Study of the Safety and Efficacy of Infliximab (Remicade) in Pediatric Patients With Crohn's DiseaseCentocor, Inc. · completed · Crohn Disease · study director
- Ph3NCT00207662 · A Safety and Efficacy Study of Infliximab (Remicade) in Patients With Moderate to Severe Active Crohn's DiseaseCentocor, Inc. · completed · Crohn Disease · study director
- Ph3NCT00207766 · A Study of the Safety and Efficacy of Infliximab (Remicade) in Subjects With Fistulizing Crohn's DiseaseCentocor, Inc. · completed · Crohn Disease · study director
- Ph2NCT00207727 · A Safety and Efficacy Study of CNTO1275 in Patients With Multiple SclerosisCentocor, Inc. · completed · Multiple Sclerosis · study director
- Ph2NCT00207714 · An Efficacy and Safety Study of CNTO 148 Subcutaneous Injection Compared With Placebo in Patients With Active Rheumatoid ArthritisCentocor, Inc. · completed · Rheumatoid Arthritis · study director
- Ph3NCT00106847 · A Study of the Safety and Effectiveness of Infliximab in Patients With Plaque-type PsoriasisCentocor, Inc. · completed · Psoriasis, Parapsoriasis · study director
- Ph3NCT00106834 · A Study of the Safety and Efficacy of Infliximab in Patients With PsoriasisCentocor, Inc. · completed · Psoriasis · study director
- Ph3NCT00096655 · A Safety and Efficacy Study for Infliximab (Remicade) in Patients With Ulcerative ColitisCentocor, Inc. · completed · Ulcerative Colitis · study director
- Ph2NCT00076726 · A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Giant Cell ArteritisCentocor, Inc. · terminated · Giant Cell Arteritis · study director
- Ph3NCT00073437 · A Study of Infliximab in Patients With SarcoidosisCentocor, Inc. · completed · Sarcoidosis · study director
- Ph3NCT00073372 · A Study of Effectiveness and Safety of Abciximab in Patients With Acute Ischemic Stroke (AbESTT-II)Centocor, Inc. · terminated · Cerebrovascular Accident, Brain Ischemia, Acute Disease · study director
- Ph2NCT00060502 · A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Pancreatic Cancer Related CachexiaCentocor, Inc. · completed · Cachexia, Pancreatic Neoplasms · study director
- Ph3NCT00056264 · A Study of Safety and Efficacy of Infliximab (Remicade) in Patients With COPDCentocor, Inc. · completed · Chronic Obstructive Pulmonary Disease, COPD · study director
- Ph3NCT00051623 · A Study of the Safety and Effectiveness of Infliximab for the Treatment of Psoriatic ArthritisCentocor, Inc. · completed · Arthritis, Psoriatic · study director
- Ph3NCT00046228 · A Study of Abciximab and Reteplase When Administered Prior to Catherization After a Myocardial Infarction (Finesse)Centocor, Inc. · completed · Myocardial Infarction · study director
- Ph3NCT00036439 · A Safety and Efficacy Study for Infliximab (Remicade) in Patients With Active Ulcerative ColitisCentocor, Inc. · completed · Ulcerative Colitis · study director
- Ph3NCT00036387 · A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Rheumatoid Arthritis.Centocor, Inc. · completed · Arthritis, Rheumatoid · study director
- Ph3NCT00036374 · A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Juvenile Rheumatoid ArthritisCentocor, Inc. · completed · Rheumatoid Arthritis, Juvenile · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:19 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 10:19 UTC. The ranking covers the 200 most relevant of 1 PubMed records, and a shared surname and initials can bring in a namesake. All 1 on PubMed